These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24844744)

  • 1. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
    Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
    J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer
    Naganawa M; Nabulsi NB; Matuskey D; Henry S; Ropchan J; Lin SF; Gao H; Pracitto R; Labaree D; Zhang MR; Suhara T; Nishino I; Sabia H; Ozaki S; Huang Y; Carson RE
    J Nucl Med; 2022 Apr; 63(4):609-614. PubMed ID: 34385336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.
    Naganawa M; Zheng MQ; Nabulsi N; Tomasi G; Henry S; Lin SF; Ropchan J; Labaree D; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Cereb Blood Flow Metab; 2014 Nov; 34(11):1818-25. PubMed ID: 25182664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
    Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
    Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
    Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
    J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid receptor binding in major depression: A pilot study.
    Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
    Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
    Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
    J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
    Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
    J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
    Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
    J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
    Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
    J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
    J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
    Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
    ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-retest reproducibility of cerebral adenosine A
    Toyohara J; Sakata M; Wagatsuma K; Tago T; Ishibashi K; Ishii K; Elsinga P; Ishiwata K
    Ann Nucl Med; 2022 Jan; 36(1):15-23. PubMed ID: 34564828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.